1-9 of 9
Nagahiro Saijo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker In Vivo

Kanae Kudo, Tokuzo Arao, Kaoru Tanaka, Tomoyuki Nagai, Kazuyuki Furuta, Kazuko Sakai, Hiroyasu Kaneda, Kazuko Matsumoto, Daisuke Tamura, Keiichi Aomatsu, Marco A. De Velasco, Yoshihiko Fujita, Nagahiro Saijo, Masatoshi Kudo, Kazuto Nishio
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (6): 1373–1381.
https://doi.org/10.1158/1078-0432.CCR-09-2755
Published: 15 March 2011
View articletitled, Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker In Vivo
Open the PDF for Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker In Vivo in another window
Includes: Supplementary data
Journal Articles

Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non–Small Cell Lung Adenocarcinoma

Kazuo Kasahara, Tokuzo Arao, Kazuko Sakai, Kazuko Matsumoto, Asao Sakai, Hideharu Kimura, Takashi Sone, Atsushi Horiike, Makoto Nishio, Tatsuo Ohira, Norihiko Ikeda, Takeharu Yamanaka, Nagahiro Saijo, Kazuto Nishio
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (18): 4616–4624.
https://doi.org/10.1158/1078-0432.CCR-10-0383
Published: 14 September 2010
View articletitled, Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non–Small Cell Lung Adenocarcinoma
Open the PDF for Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non–Small Cell Lung Adenocarcinoma in another window
Journal Articles

Performing Phase I Clinical Trials of Anticancer Agents: Perspectives from within the European Union and Japan

Martin D. Forster, Nagahiro Saijo, Lesley Seymour, Hilary Calvert
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (6): 1737–1744.
https://doi.org/10.1158/1078-0432.CCR-09-2228
Published: 14 March 2010
View articletitled, Performing Phase I Clinical Trials of Anticancer Agents: Perspectives from within the European Union and Japan
Open the PDF for Performing Phase I Clinical Trials of Anticancer Agents: Perspectives from within the European Union and Japan in another window
Journal Articles

Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B12 in Previously Treated Patients with Non-Small Cell Lung Cancer

Yuichiro Ohe, Yukito Ichinose, Kazuhiko Nakagawa, Tomohide Tamura, Kaoru Kubota, Nobuyuki Yamamoto, Susumu Adachi, Yoshihiro Nambu, Toshio Fujimoto, Yutaka Nishiwaki, Nagahiro Saijo, Masahiro Fukuoka
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (13): 4206–4212.
https://doi.org/10.1158/1078-0432.CCR-07-5143
Published: 01 July 2008
View articletitled, Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B12 in Previously Treated Patients with Non-Small Cell Lung Cancer
Open the PDF for Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B12 in Previously Treated Patients with Non-Small Cell Lung Cancer in another window
Journal Articles

AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor

Masayuki Takeda, Tokuzo Arao, Hideyuki Yokote, Teruo Komatsu, Kazuyoshi Yanagihara, Hiroki Sasaki, Yasuhide Yamada, Tomohide Tamura, Kazuya Fukuoka, Hiroshi Kimura, Nagahiro Saijo, Kazuto Nishio
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 3051–3057.
https://doi.org/10.1158/1078-0432.CCR-06-2743
Published: 15 May 2007
View articletitled, AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor
Open the PDF for AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor in another window
Journal Articles

Enhancement of Sensitivity to Tumor Necrosis Factor α in Non–Small Cell Lung Cancer Cells with Acquired Resistance to Gefitinib

Koichi Ando, Tohru Ohmori, Fumiko Inoue, Tsuyoki Kadofuku, Takamichi Hosaka, Hiroo Ishida, Takao Shirai, Kentaro Okuda, Takashi Hirose, Naoya Horichi, Kazuto Nishio, Nagahiro Saijo, Mitsuru Adachi, Toshio Kuroki
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8872–8879.
https://doi.org/10.1158/1078-0432.CCR-05-0811
Published: 16 December 2005
View articletitled, Enhancement of Sensitivity to Tumor Necrosis Factor α in Non–Small Cell Lung Cancer Cells with Acquired Resistance to Gefitinib
Open the PDF for Enhancement of Sensitivity to Tumor Necrosis Factor α in Non–Small Cell Lung Cancer Cells with Acquired Resistance to Gefitinib in another window
Journal Articles

Pilot Study of Concurrent Etoposide and Cisplatin Plus Accelerated Hyperfractionated Thoracic Radiotherapy Followed by Irinotecan and Cisplatin for Limited-Stage Small Cell Lung Cancer: Japan Clinical Oncology Group 9903

Kaoru Kubota, Yutaka Nishiwaki, Takahiko Sugiura, Kazumasa Noda, Kiyoshi Mori, Masaaki Kawahara, Shunichi Negoro, Koshiro Watanabe, Fumio Imamura, Tomohide Tamura, Nagahiro Saijo
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (15): 5534–5538.
https://doi.org/10.1158/1078-0432.CCR-04-1771
Published: 01 August 2005
View articletitled, Pilot Study of Concurrent Etoposide and Cisplatin Plus Accelerated Hyperfractionated Thoracic Radiotherapy Followed by Irinotecan and Cisplatin for Limited-Stage Small Cell Lung Cancer: Japan Clinical Oncology Group 9903
Open the PDF for Pilot Study of Concurrent Etoposide and Cisplatin Plus Accelerated Hyperfractionated Thoracic Radiotherapy Followed by Irinotecan and Cisplatin for Limited-Stage Small Cell Lung Cancer: Japan Clinical Oncology Group 9903 in another window
Journal Articles

Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the Cytidine Deaminase Gene in a Japanese Cancer Patient Treated with Gemcitabine plus Cisplatin

Kan Yonemori, Hideki Ueno, Takuji Okusaka, Noboru Yamamoto, Masafumi Ikeda, Nagahiro Saijo, Teruhiko Yoshida, Hiroshi Ishii, Junji Furuse, Emiko Sugiyama, Su-Ryang Kim, Ruri Kikura-Hanajiri, Ryuichi Hasegawa, Yoshiro Saito, Shogo Ozawa, Nahoko Kaniwa, Jun-ichi Sawada
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (7): 2620–2624.
https://doi.org/10.1158/1078-0432.CCR-04-1497
Published: 06 April 2005
View articletitled, Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the Cytidine Deaminase Gene in a Japanese Cancer Patient Treated with Gemcitabine plus Cisplatin
Open the PDF for Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the Cytidine Deaminase Gene in a Japanese Cancer Patient Treated with Gemcitabine plus Cisplatin in another window
Journal Articles

In Vitro Synergistic Interactions between the Cisplatin Analogue Nedaplatin and the DNA Topoisomerase I Inhibitor Irinotecan and the Mechanism of this Interaction

Fumihiko Kanzawa, Fumiaki Koizumi, Yasuhiro Koh, Takashi Nakamura, Yasuaki Tatsumi, Hisao Fukumoto, Nagahiro Saijo, Takayuki Yoshioka, Kazuto Nishio
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (1): 202–209.
Published: 01 January 2001
View articletitled, In Vitro Synergistic Interactions between the Cisplatin Analogue Nedaplatin and the DNA Topoisomerase I Inhibitor Irinotecan and the Mechanism of this Interaction
Open the PDF for In Vitro Synergistic Interactions between the Cisplatin Analogue Nedaplatin and the DNA Topoisomerase I Inhibitor Irinotecan and the Mechanism of this Interaction in another window